- Home
- SSB vs QGEN Comparison
SSB vs QGEN Comparison
Compare SSB & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSB
- QGEN
- Stock Information
- Founded
- SSB 1933
- QGEN 1986
- Country
- SSB United States
- QGEN Netherlands
- Employees
- SSB N/A
- QGEN N/A
- Industry
- SSB Major Banks
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SSB Finance
- QGEN Health Care
- Exchange
- SSB Nasdaq
- QGEN Nasdaq
- Market Cap
- SSB 9.3B
- QGEN 9.1B
- IPO Year
- SSB 1997
- QGEN 1996
- Fundamental
- Price
- SSB $87.80
- QGEN $45.14
- Analyst Decision
- SSB Strong Buy
- QGEN Buy
- Analyst Count
- SSB 11
- QGEN 8
- Target Price
- SSB $117.20
- QGEN $50.53
- AVG Volume (30 Days)
- SSB 768.2K
- QGEN 1.5M
- Earning Date
- SSB 07-23-2025
- QGEN 05-07-2025
- Dividend Yield
- SSB 2.46%
- QGEN 2.92%
- EPS Growth
- SSB N/A
- QGEN N/A
- EPS
- SSB 6.12
- QGEN 0.42
- Revenue
- SSB $1,829,006,000.00
- QGEN $2,002,874,000.00
- Revenue This Year
- SSB $54.78
- QGEN $6.11
- Revenue Next Year
- SSB $5.58
- QGEN $6.10
- P/E Ratio
- SSB $14.34
- QGEN $107.32
- Revenue Growth
- SSB 13.69
- QGEN 3.31
- 52 Week Low
- SSB $70.68
- QGEN $37.63
- 52 Week High
- SSB $114.27
- QGEN $47.93
- Technical
- Relative Strength Index (RSI)
- SSB 46.07
- QGEN 66.03
- Support Level
- SSB $85.62
- QGEN $41.77
- Resistance Level
- SSB $90.05
- QGEN $43.01
- Average True Range (ATR)
- SSB 1.81
- QGEN 0.70
- MACD
- SSB -0.24
- QGEN 0.24
- Stochastic Oscillator
- SSB 25.23
- QGEN 93.82
About SSB SouthState Corporation
SouthState Corp is a United States-based bank holding company. It provides a wide range of services and products to its customers through a wholly-owned bank subsidiary, South State Bank. The Bank provides retail and commercial banking services, mortgage lending services, trust and investment services, and consumer finance loans through financial centers in Alabama, Florida, Georgia, North Carolina, South Carolina, and Virginia. These services include demand, time and savings deposits, lending and credit card servicing, ATM processing, and wealth management and trust services.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).